Metalloproteases in Pain Generation and Persistence: A Possible Target?

Biomolecules. 2023 Jan 31;13(2):268. doi: 10.3390/biom13020268.

Abstract

Matrix metalloproteinases (MMPs) are a large family of zinc-dependent proteolytic enzymes associated with extracellular matrix protein turnover and tissue degradation. They participate to many different physiological reactions but are also hyperactivated in several diseases. Various literature studies have documented that MMPs play a role in the modulation of neuropathic and nociceptive pain. The heterogeneity of clinical and pre-clinical data is an important issue in this experimental context. Despite the presence of a good number of studies on MMP inhibitors, these drugs showed scarce efficacy and relevant side effects. In the present manuscript, we reviewed studies in the literature that define a possible role of MMPs in pain and the effects of their modulation.

Keywords: MMP inhibitors; MMPs; low back pain; neuropathic pain; osteoarthritis.

Publication types

  • Review

MeSH terms

  • Humans
  • Matrix Metalloproteinase Inhibitors* / pharmacology
  • Matrix Metalloproteinases* / metabolism
  • Pain

Substances

  • Matrix Metalloproteinase Inhibitors
  • Matrix Metalloproteinases

Grants and funding

This research received no external funding.